Bionano Genomics Inc (BNGO)
0.9516
+0.01
(+0.69%)
USD |
NASDAQ |
May 03, 13:20
Bionano Genomics Research and Development Expense (Quarterly): 11.70M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.70M |
| September 30, 2023 | 13.78M |
| June 30, 2023 | 14.61M |
| March 31, 2023 | 13.94M |
| December 31, 2022 | 14.01M |
| September 30, 2022 | 12.74M |
| June 30, 2022 | 11.77M |
| March 31, 2022 | 10.53M |
| December 31, 2021 | 9.215M |
| September 30, 2021 | 6.505M |
| June 30, 2021 | 4.086M |
| March 31, 2021 | 2.678M |
| December 31, 2020 | 2.877M |
| September 30, 2020 | 2.304M |
| Date | Value |
|---|---|
| June 30, 2020 | 2.401M |
| March 31, 2020 | 2.674M |
| December 31, 2019 | 2.399M |
| September 30, 2019 | 2.174M |
| June 30, 2019 | 2.408M |
| March 31, 2019 | 2.10M |
| December 31, 2018 | 2.522M |
| September 30, 2018 | 2.505M |
| June 30, 2018 | 2.099M |
| March 31, 2018 | 2.367M |
| December 31, 2017 | 2.458M |
| September 30, 2017 | 2.967M |
| June 30, 2017 | 3.394M |
| March 31, 2017 | 3.190M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.174M
Minimum
Sep 2019
14.61M
Maximum
Jun 2023
7.516M
Average
6.505M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp | 83.50M |
| Azenta Inc | 8.493M |
| Harvard Bioscience Inc | 3.15M |
| Akoya Biosciences Inc | 4.67M |
| Singular Genomics Systems Inc | 11.69M |